30
Participants
Start Date
October 5, 2023
Primary Completion Date
June 1, 2027
Study Completion Date
June 30, 2027
Empagliflozin 25 MG
A medication used in the management and treatment of type 2 diabetes mellitus. It is in the sodium-glucose co-transporter (SGLT-2) class of medications.
Placebo
Inert tablet
RECRUITING
Texas Diabetes Institute/UH, San Antonio
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
The University of Texas Health Science Center at San Antonio
OTHER